QIZENDAY Trademark

Trademark Overview

On Friday, February 10, 2017, a trademark application was filed for QIZENDAY with the United States Patent and Trademark Office. The USPTO has given the QIZENDAY trademark a serial number of 79207033. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 25, 2024. This trademark is owned by MedDay Pharmaceuticals, Société Anonyme. The QIZENDAY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of nervous system disorders, veterinary products for the treatment of nervous system disorders, chemical preparations for medical or pharmaceutical use for the treatment of nervous system disorders, medicinal herbs
qizenday

General Information

Serial Number79207033
Word MarkQIZENDAY
Filing DateFriday, February 10, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 25, 2024
Registration Number5440474
Registration DateTuesday, April 10, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements

Goods and Servicespharmaceutical products for the treatment of nervous system disorders, veterinary products for the treatment of nervous system disorders, chemical preparations for medical or pharmaceutical use for the treatment of nervous system disorders, medicinal herbs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedDay Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameMedDay Pharmaceuticals, Société Anonyme
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameMedDay Pharmaceuticals, Société Anonyme
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Monday, May 15, 2017NON-FINAL ACTION WRITTEN
Thursday, May 11, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 12, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, May 16, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 26, 2017REFUSAL PROCESSED BY MPU
Friday, May 26, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 17, 2017REFUSAL PROCESSED BY IB
Monday, November 6, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 6, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2017ASSIGNED TO LIE
Monday, November 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 3, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, January 19, 2018NOTIFICATION PROCESSED BY IB
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, July 30, 2018FINAL DISPOSITION PROCESSED
Tuesday, December 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Monday, July 30, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 10, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SECTION 71
Saturday, May 15, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 24, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 11, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, November 29, 2018NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

qizenday system nervous disorders treatment pharmaceutical products medicinal herbs medical chemical